APA (7th ed.) Citation

Harai, N., Kawaguchi, Y., Hanihara, M., Ichijo, M., Ichikawa, D., Uchinuma, H., & Tsuchiya, K. (2023). Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat. Internal Medicine, 62(20), 3005-3011. https://doi.org/10.2169/internalmedicine.1425-22

Chicago Style (17th ed.) Citation

Harai, Nozomi, Yoshihiko Kawaguchi, Mitsuto Hanihara, Masashi Ichijo, Daisuke Ichikawa, Hiroyuki Uchinuma, and Kyoichiro Tsuchiya. "Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat." Internal Medicine 62, no. 20 (2023): 3005-3011. https://doi.org/10.2169/internalmedicine.1425-22.

MLA (9th ed.) Citation

Harai, Nozomi, et al. "Gaucher Disease Types I and III Responded Well to Substrate Reduction Therapy Using Eliglustat." Internal Medicine, vol. 62, no. 20, 2023, pp. 3005-3011, https://doi.org/10.2169/internalmedicine.1425-22.